Neurochemical Journal

, Volume 11, Issue 4, pp 302–308 | Cite as

An effector analysis of the interaction of propoxazepam with antagonists of GABA and glycine receptors

  • N. Ya. GolovenkoEmail author
  • V. B. Larionov
  • A. S. Reder
  • I. P. Valivodz’
Experimental Articles


Using effector analysis, we studied the mechanism of anti-seizure activity of the alcoxy-derived benzodiazepine (propoxazepam). In models of chemically induced seizures we determined the average molar and weight effective doses (ED50) of propoxazepam as an antagonist of picrotoxin (4.10 ± 0.21 μmol/kg, 1.67 ± 0.09 mg/kg), pentylenetetrazole (2.24 ± 0.93 μmol/kg, 0.9 ± 0.04 mg/kg), and strychnine (40.33 ± 14.91 μmol/kg, 14.24 ± 0.47 mg/kg), which reflect the high activity level of the substance. On the basis of dose–effect curves, using comparative quantile analysis for chemoconvulsants with different mechanisms of action, we showed different stages of interaction of propoxazepam with GABA and glycine receptors under in vivo conditions. We evaluated the partial contribution of myoclonic and toxic components to the general structure of seizures induced by various chemoconvulsants. We believe that the results we obtained indicate that the anti-seizure action of propoxazepam is predominantly mediated by a GABAergic mechanism. Glycinergic components of the inhibition of strychnine-induced seizures by propoxazepam occur at doses that exceed the ED50 and seem to be an additional means of anti-seizure action.


propoxazepam chemoconvulsants antiseizure action GABA antagonists 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Pavlovsky, V.I., Tsymbalyuk, O.V., Martynyuk, V.S., Kabanova, T.A., Semenishyna, E.A., Khalimova, E.I., and Andronati, S.A., Neurophysiology, 2013, vol. 45, nos 5-6, pp. 427–432.CrossRefGoogle Scholar
  2. 2.
    Golovenko, N.Ya., Larionov, V.B., and Reder, A.S., Voloshchuk N.I., Valivodz I.P., Taran I.V, Zhurn. Natsional’noi Akademii Meditsinskikh Nauk Ukrainy, 2016, no. 3, pp. 251–260.Google Scholar
  3. 3.
    Bryans, J.S. and Wustrow, D.J., Med. Res. Rev., 1999, vol. 19, pp. 149–177.CrossRefPubMedGoogle Scholar
  4. 4.
    Pavlovskii, V.I., Kabanova, T.A., Khalimova, E.I., and Andronati, S.A., Vestnik Odesskogo Natsional’nogo Universiteta. Seriya “Khimiya”, 2013, vol. 18, no. 3, pp. 28–38.Google Scholar
  5. 5.
    Urbakh, V.Yu., in Statisticheskii analiz v biologicheskikh i meditsinskikh issledovaniyakh (Statistical Analysis in Medical Studies), Moscow: Meditsina, 1975.Google Scholar
  6. 6.
    Varden, B., in Matematicheskaya statistika (Mathematical Statistics), Moscow: Izd-vo Inostr. Lit, 1960.Google Scholar
  7. 7.
    Buchinsky, M., J. Human Resources, 1998, vol. 33, no. 1, pp. 88–126.CrossRefGoogle Scholar
  8. 8.
    Koenker, R., Quantile Regression, University of Illinois, Urbana-Champaign, 2005, p. 368.CrossRefGoogle Scholar
  9. 9.
    Imming, P., Sinning, C., and Meyer, A., Drug Discovery, 2006, vol. 5, pp. 821–834.CrossRefPubMedGoogle Scholar
  10. 10.
    Amakhin, D.V. and Veselkin, N.P., Tsitologiya, 2012, no. 6, pp. 469–477.Google Scholar
  11. 11.
    Danilov, A.B. and Davydov, O.S., in Neiropaticheskaya bol’ (Neuropathic Pain), Moscow: Borges, 2007.Google Scholar
  12. 12.
    Jung, M.E. and Lai, H., Neurosci. Biobehav. Rev., 2002, vol. 26, no. 4, pp. P. 429–439.CrossRefPubMedGoogle Scholar
  13. 13.
    Carlton, S.M., Zhou, S., and Coggeshall, R.E., Neuroscience, 1999, vol. 93, no. 2, pp. 713–722.CrossRefPubMedGoogle Scholar
  14. 14.
    Ramanyaneyulu, R. and Ticku, M.K., Eur. J. Pharmacol., 1984, vol. 98, pp. 337–345.CrossRefGoogle Scholar
  15. 15.
    Bloom, P., Madeja, M., Mushhoff, U., and Specmann, E.-J., Neurosci. Let., 1996, vol. 205, pp. 115–118.CrossRefGoogle Scholar
  16. 16.
    Vauquelin, G., Van Liefde, I., and Vanderheyden, P., Trends in Pharmacological Sciences, 2002, vol. 23, no. 11, pp. 514–518.CrossRefPubMedGoogle Scholar

Copyright information

© Pleiades Publishing, Ltd. 2017

Authors and Affiliations

  • N. Ya. Golovenko
    • 1
    • 2
    Email author
  • V. B. Larionov
    • 1
  • A. S. Reder
    • 1
  • I. P. Valivodz’
    • 1
  1. 1.Bogatskii Physicochemical InstituteNational Academy of SciencesOdessaUkraine
  2. 2.OdessaUkraine

Personalised recommendations